Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EVERSPIN TECHNOLOGIES INC.MRAM · Entity 5701 | Director | May 19, 2020 | May 20, 2020 |
| Eikon Therapeutics, Inc.EIKN · Entity 5380 | 10% owner | February 04, 2026 | February 06, 2026 |
| Lux Health Tech Acquisition Corp.LUXA · Entity 145615 | 10% owner | October 29, 2020 | November 02, 2020 |
| Science 37 Holdings, Inc.SNCE · Entity 15235 | 10% owner | April 04, 2022 | April 06, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EVERSPIN TECHNOLOGIES INC.
Report date May 19, 2020 · Filed May 20, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,131 |
Reported balance
After 2020-05-19 transaction · row 1
1 source rowRow 1 · 2020-05-19 · Grant · Acquired 20,131 · Balance 29,131 |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 1,015,550 |
Reported balance
Holding disclosure · report date 2020-05-19 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,015,550 F1: Lux Venture Partners II, L.P. ("LVPII") is the general partner of LVII and Sidecar. Lux Venture Associates II, LLC ("LVAII") is the general partner of LVPII and Lux Capital Management, LLC ("LCM LLC") is the sole member of LVAII. Mr. Hebert is an individual manager of LCM LLC. The shares are held as follows: 974,678 by LV II and 40,872 by Sidecar.LCM LLC, as sole member of LVAII, may be deemed to share voting and investment powers for the shares held by LVII and Sidecar. Mr. Hebert disclaims beneficial ownership over the shares reported herein, and this report shall not be deemed an admission of beneficial ownership for the purposes of Section 16 or for any other purpose, except to the extent of his proportionate pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Lux Venture Partners II, L.P. ("LVPII") is the general partner of LVII and Sidecar. Lux Venture Associates II, LLC ("LVAII") is the general partner of LVPII and Lux Capital Management, LLC ("LCM LLC") is the sole member of LVAII. Mr. Hebert is an individual manager of LCM LLC. The shares are held as follows: 974,678 by LV II and 40,872 by Sidecar.LCM LLC, as sole member of LVAII, may be deemed to share voting and investment powers for the shares held by LVII and Sidecar. Mr. Hebert disclaims beneficial ownership over the shares reported herein, and this report shall not be deemed an admission of beneficial ownership for the purposes of Section 16 or for any other purpose, except to the extent of his proportionate pecuniary interest therein.
Eikon Therapeutics, Inc.
Report date February 04, 2026 · Filed February 06, 2026
Jointly reported with Lux Venture Partners V, LLC, Wolfe Josh, Lux Ventures V, L.P., Lux Co-Invest Opportunities II, L.P., Lux Total Opportunities, L.P.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 138,888 |
Reported balance
After 2026-02-04 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2026-02-04 · Purchase · Acquired 138,888 · Balance 138,888 F1: These shares are held by Lux Co-Invest Opportunities II, L.P. ("LCIO II"). Lux Co-Invest Partners II, LLC ("LCIP II") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the "Individual Lux Managers"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 138,888 |
Reported balance
After 2026-02-04 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2026-02-04 · Purchase · Acquired 138,888 · Balance 138,888 F2: These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 2,387,705 |
Reported balance
After 2026-02-06 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2026-02-06 · Conversion · Acquired 2,387,705 · Balance 2,387,705 F3: The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date. F4: The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F5: These shares are held by Lux Ventures V, L.P. ("LVV"). Lux Venture Partners V, LLC ("LVPV") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 1,290,428 |
Reported balance
After 2026-02-06 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2026-02-06 · Conversion · Acquired 1,151,540 · Balance 1,290,428 F4: The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F6: The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F7: The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F1: These shares are held by Lux Co-Invest Opportunities II, L.P. ("LCIO II"). Lux Co-Invest Partners II, LLC ("LCIP II") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the "Individual Lux Managers"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 2,294,653 |
Reported balance
After 2026-02-06 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2026-02-06 · Conversion · Acquired 2,155,765 · Balance 2,294,653 F6: The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F7: The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F8: The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F9: The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F10: The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F2: These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. |
| Series A Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2026-02-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-02-06 · Conversion · Disposed 10,000,000 · Balance 0 F3: The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date. F5: These shares are held by Lux Ventures V, L.P. ("LVV"). Lux Venture Partners V, LLC ("LVPV") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. |
| Series A-1 Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2026-02-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-02-06 · Conversion · Disposed 7,807,026 · Balance 0 F4: The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F5: These shares are held by Lux Ventures V, L.P. ("LVV"). Lux Venture Partners V, LLC ("LVPV") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. |
| Series A-1 Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2026-02-06 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-02-06 · Conversion · Disposed 2,502,252 · Balance 0 F4: The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F1: These shares are held by Lux Co-Invest Opportunities II, L.P. ("LCIO II"). Lux Co-Invest Partners II, LLC ("LCIP II") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the "Individual Lux Managers"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein. |
| Series B Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2026-02-06 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-02-06 · Conversion · Disposed 796,380 · Balance 0 F6: The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F1: These shares are held by Lux Co-Invest Opportunities II, L.P. ("LCIO II"). Lux Co-Invest Partners II, LLC ("LCIP II") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the "Individual Lux Managers"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein. |
| Series B Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2026-02-06 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-02-06 · Conversion · Disposed 530,920 · Balance 0 F6: The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F2: These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. |
| Series B-1 Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2026-02-06 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-02-06 · Conversion · Disposed 5,289,322 · Balance 0 F7: The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F1: These shares are held by Lux Co-Invest Opportunities II, L.P. ("LCIO II"). Lux Co-Invest Partners II, LLC ("LCIP II") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the "Individual Lux Managers"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein. |
| Series B-1 Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2026-02-06 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2026-02-06 · Conversion · Disposed 3,526,215 · Balance 0 F7: The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F2: These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. |
| Series C Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2026-02-06 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2026-02-06 · Conversion · Disposed 303,360 · Balance 0 F8: The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F2: These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. |
| Series C-1 Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2026-02-06 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2026-02-06 · Conversion · Disposed 1,450,614 · Balance 0 F9: The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F2: These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. |
| Series D Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2026-02-06 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2026-02-06 · Conversion · Disposed 10,266,152 · Balance 0 F10: The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F2: These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are held by Lux Co-Invest Opportunities II, L.P. ("LCIO II"). Lux Co-Invest Partners II, LLC ("LCIP II") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the "Individual Lux Managers"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.
F2: These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein.
F3: The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date.
F4: The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.
F5: These shares are held by Lux Ventures V, L.P. ("LVV"). Lux Venture Partners V, LLC ("LVPV") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein.
F6: The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.
F7: The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.
F8: The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.
F9: The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.
F10: The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.
Lux Health Tech Acquisition Corp.
Report date October 29, 2020 · Filed November 02, 2020
Jointly reported with Lux Encore Sponsor, LP, Lux Encore Holdings, LLC, Wolfe Josh
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 | IndirectSee footnote | 5,933,333 |
Reported balance
After 2020-10-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-10-29 · Purchase · Acquired 5,933,333 · Balance 5,933,333 F1: The warrants will become exercisable commencing on the later of 12 months from the closing of the Issuer's initial public offering or 30 days after the completion of the Issuer's initial business combination, and will expire five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation. F2: Lux Encore Sponsor, LP ("Sponsor") is the record holder of the warrants reported herein. Lux Encore Holdings, LLC ("Lux GP") is the general partner of Sponsor. Josh Wolfe and Peter Hebert are the managing members of Lux GP. As such, Lux GP and each of Messers. Wolfe and Hebert may be deemed to share beneficial ownership of the warrants held directly by Sponsor. Lux GP and Messers. Wolfe and Hebert disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: The warrants will become exercisable commencing on the later of 12 months from the closing of the Issuer's initial public offering or 30 days after the completion of the Issuer's initial business combination, and will expire five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation.
F2: Lux Encore Sponsor, LP ("Sponsor") is the record holder of the warrants reported herein. Lux Encore Holdings, LLC ("Lux GP") is the general partner of Sponsor. Josh Wolfe and Peter Hebert are the managing members of Lux GP. As such, Lux GP and each of Messers. Wolfe and Hebert may be deemed to share beneficial ownership of the warrants held directly by Sponsor. Lux GP and Messers. Wolfe and Hebert disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein, if any.
Science 37 Holdings, Inc.
Report date April 04, 2022 · Filed April 06, 2022
Jointly reported with Lux Capital Management, LLC, Lux Ventures IV, L.P., Lux Venture Partners IV, LLC, Lux Co-Invest Opportunities, L.P., Lux Co-Invest Partners, LLC, Wolfe Josh
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Lux Ventures IV, L.P. | 8,743,999 |
Reported balance
After 2022-04-04 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2022-04-04 · Other · Disposed 2,914,667 · Balance 8,743,999 F1: Pro rata distribution of 2,914,667 shares from Lux Ventures IV, L.P. to its partners. F2: Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares held by Lux Ventures IV, L.P. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares held by Lux Co-Invest Opportunities, L.P. Peter Hebert and Joshua Wolfe are the individual managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC and may be deemed to share voting and dispositive power over the shares held by each of Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P., Lux Capital Management, LLC, as the investment manager for each of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power over the shares held by each of Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P. F3: Each of Lux Capital Management, LLC, Lux Venture Partners IV, LLC, Lux Co-Invest Partners, LLC, Peter Hebert and Joshua Wolfe disclaim beneficial ownership over the shares reported herein except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | IndirectBy Lux Co-Invest Opportunities, L.P. | 3,505,890 |
Reported balance
Holding disclosure · report date 2022-04-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,505,890 F2: Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares held by Lux Ventures IV, L.P. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares held by Lux Co-Invest Opportunities, L.P. Peter Hebert and Joshua Wolfe are the individual managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC and may be deemed to share voting and dispositive power over the shares held by each of Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P., Lux Capital Management, LLC, as the investment manager for each of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power over the shares held by each of Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P. F3: Each of Lux Capital Management, LLC, Lux Venture Partners IV, LLC, Lux Co-Invest Partners, LLC, Peter Hebert and Joshua Wolfe disclaim beneficial ownership over the shares reported herein except to the extent of their pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: Pro rata distribution of 2,914,667 shares from Lux Ventures IV, L.P. to its partners.
F2: Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares held by Lux Ventures IV, L.P. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares held by Lux Co-Invest Opportunities, L.P. Peter Hebert and Joshua Wolfe are the individual managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC and may be deemed to share voting and dispositive power over the shares held by each of Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P., Lux Capital Management, LLC, as the investment manager for each of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power over the shares held by each of Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P.
F3: Each of Lux Capital Management, LLC, Lux Venture Partners IV, LLC, Lux Co-Invest Partners, LLC, Peter Hebert and Joshua Wolfe disclaim beneficial ownership over the shares reported herein except to the extent of their pecuniary interest therein, if any.
Past disclosures · reporting ended (4)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Aeva Technologies, Inc.
Report date August 05, 2022 · Filed August 09, 2022
Jointly reported with Wolfe Josh, Lux Ventures IV, L.P., Lux Co-Invest Opportunities, L.P., Lux Venture Partners IV, LLC, Lux Co-Invest Partners, LLC
Section 16 reporting ended · disclosed 2022-08-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 14,692,316 |
Reported balance
After 2022-08-05 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2022-08-05 · Other · Disposed 7,346,159 · Balance 14,692,316 F1: Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 1,959,371 |
Reported balance
Holding disclosure · report date 2022-08-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,959,371 F2: These shares are owned directly by Lux Co-Invest Opportunities, L.P. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. The Individual Lux Managers are the individual managing members of Lux Co-Invest Partners, LLC. The Individual Lux Managers, as the sole managers of Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Co-Invest Opportunities, L.P. Each of Lux Co-Invest Partners, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest. |
Filing footnotes · ownership attribution and instrument terms
F1: Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein.
F2: These shares are owned directly by Lux Co-Invest Opportunities, L.P. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. The Individual Lux Managers are the individual managing members of Lux Co-Invest Partners, LLC. The Individual Lux Managers, as the sole managers of Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Co-Invest Opportunities, L.P. Each of Lux Co-Invest Partners, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest.
Latch, Inc.
Report date September 28, 2021 · Filed October 05, 2021
Jointly reported with Lux Ventures IV, L.P., Lux Venture Partners IV, LLC, Lux Co-Invest Opportunities, L.P., Lux Co-Invest Partners, LLC, Wolfe Josh
Section 16 reporting ended · disclosed 2021-10-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 7,228,469 |
Reported balance
After 2021-09-28 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-09-28 · Other · Disposed 2,409,489 · Balance 7,228,469 F1: Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 4,084,493 |
Reported balance
After 2021-09-28 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2021-09-28 · Other · Disposed 1,358,164 · Balance 4,084,493 F2: Pro rata distribution from Lux Co-Invest Opportunities, L.P. to its partners. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. The Individual Lux Managers are the individual managing members of Lux Co-Invest Partners, LLC. The Individual Lux Managers, as the sole managers of Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Co-Invest Opportunities, L.P. Each of Lux Co-Invest Partners, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest. |
Filing footnotes · ownership attribution and instrument terms
F1: Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein.
F2: Pro rata distribution from Lux Co-Invest Opportunities, L.P. to its partners. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. The Individual Lux Managers are the individual managing members of Lux Co-Invest Partners, LLC. The Individual Lux Managers, as the sole managers of Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Co-Invest Opportunities, L.P. Each of Lux Co-Invest Partners, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest.
Matterport, Inc./DE
Report date February 28, 2025 · Filed March 03, 2025
Section 16 reporting ended · disclosed 2025-03-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-02-28 transaction · row 1
1 source rowRow 1 · 2025-02-28 · Disposition to issuer · Disposed 279,793 · Balance 0 F1: In connection with the consummation of the transactions contemplated by the merger agreement (the "Merger Agreement"), dated as of April 21, 2024, by and among the Issuer, CoStar Group, Inc. ("CoStar Group") and the other parties thereto, each share of the Issuer's Class A common stock held by the Reporting Person was converted into the right to receive an amount in cash equal to $2.75 per share plus 0.03552 shares of common stock of CoStar Group (the "Merger Consideration"). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-02-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-02-28 · Disposition to issuer · Disposed 39,325 · Balance 0 F2: Each restricted stock unit that became fully vested automatically as a result of the consummation of the transactions (the "Closing") contemplated by the Merger Agreement (the "Accelerated Matterport RSUs") was cancelled and converted into the right to receive the Merger Consideration, and all other restricted stock units outstanding as of the effective time of the Closing were converted into a corresponding award in respect of CoStar Group Common Stock based on the Equity Award Conversion Factor (as determined in accordance with the formula in the Merger Agreement). |
Filing footnotes · ownership attribution and instrument terms
F1: In connection with the consummation of the transactions contemplated by the merger agreement (the "Merger Agreement"), dated as of April 21, 2024, by and among the Issuer, CoStar Group, Inc. ("CoStar Group") and the other parties thereto, each share of the Issuer's Class A common stock held by the Reporting Person was converted into the right to receive an amount in cash equal to $2.75 per share plus 0.03552 shares of common stock of CoStar Group (the "Merger Consideration").
F2: Each restricted stock unit that became fully vested automatically as a result of the consummation of the transactions (the "Closing") contemplated by the Merger Agreement (the "Accelerated Matterport RSUs") was cancelled and converted into the right to receive the Merger Consideration, and all other restricted stock units outstanding as of the effective time of the Closing were converted into a corresponding award in respect of CoStar Group Common Stock based on the Equity Award Conversion Factor (as determined in accordance with the formula in the Merger Agreement).
RECURSION PHARMACEUTICALS, INC.
Report date December 07, 2021 · Filed December 09, 2021
Jointly reported with Lux Ventures IV, L.P., Lux Venture Partners IV, LLC, Lux Co-Invest Opportunities, L.P., Lux Co-Invest Partners, LLC, Wolfe Josh
Section 16 reporting ended · disclosed 2021-12-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stockSEC Table I · non-derivative | Direct | 13,021,519 |
Reported balance
After 2021-12-07 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-12-07 · Other · Disposed 4,265,576 · Balance 13,021,519 F1: Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 06, 2026 Filed Feb 6, 2026 18:25 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | ConversionSeries D Preferred Stock · Derivative | 10,266,152 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-041544 · ownership.xml · derivative · entry 15 Lux Venture Partners V, LLC · CIK 0001698118 · 10% owner Wolfe Josh · CIK 0001830001 · Director · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Lux Ventures V, L.P. · CIK 0001698008 · 10% owner Lux Co-Invest Opportunities II, L.P. · CIK 0001783916 · 10% owner Lux Total Opportunities, L.P. · CIK 0001864658 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 1,376,566 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F10 · price: The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F10 · derivative.exercise_date: The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F10 · derivative.expiration_date: The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F2 · ownership.nature: These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 18:25 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | ConversionSeries C-1 Preferred Stock · Derivative | 1,450,614 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-041544 · ownership.xml · derivative · entry 14 Lux Venture Partners V, LLC · CIK 0001698118 · 10% owner Wolfe Josh · CIK 0001830001 · Director · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Lux Ventures V, L.P. · CIK 0001698008 · 10% owner Lux Co-Invest Opportunities II, L.P. · CIK 0001783916 · 10% owner Lux Total Opportunities, L.P. · CIK 0001864658 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 194,510 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F9 · price: The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F9 · derivative.exercise_date: The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F9 · derivative.expiration_date: The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F2 · ownership.nature: These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 18:25 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | ConversionSeries C Preferred Stock · Derivative | 303,360 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-041544 · ownership.xml · derivative · entry 13 Lux Venture Partners V, LLC · CIK 0001698118 · 10% owner Wolfe Josh · CIK 0001830001 · Director · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Lux Ventures V, L.P. · CIK 0001698008 · 10% owner Lux Co-Invest Opportunities II, L.P. · CIK 0001783916 · 10% owner Lux Total Opportunities, L.P. · CIK 0001864658 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 40,677 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F8 · price: The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F8 · derivative.exercise_date: The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F8 · derivative.expiration_date: The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F2 · ownership.nature: These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 18:25 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | ConversionSeries B-1 Preferred Stock · Derivative | 3,526,215 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-041544 · ownership.xml · derivative · entry 12 Lux Venture Partners V, LLC · CIK 0001698118 · 10% owner Wolfe Josh · CIK 0001830001 · Director · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Lux Ventures V, L.P. · CIK 0001698008 · 10% owner Lux Co-Invest Opportunities II, L.P. · CIK 0001783916 · 10% owner Lux Total Opportunities, L.P. · CIK 0001864658 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 472,822 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F7 · price: The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F7 · derivative.exercise_date: The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F7 · derivative.expiration_date: The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F2 · ownership.nature: These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 18:25 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | ConversionSeries B-1 Preferred Stock · Derivative | 5,289,322 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-041544 · ownership.xml · derivative · entry 11 Lux Venture Partners V, LLC · CIK 0001698118 · 10% owner Wolfe Josh · CIK 0001830001 · Director · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Lux Ventures V, L.P. · CIK 0001698008 · 10% owner Lux Co-Invest Opportunities II, L.P. · CIK 0001783916 · 10% owner Lux Total Opportunities, L.P. · CIK 0001864658 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 709,234 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F7 · price: The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F7 · derivative.exercise_date: The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F7 · derivative.expiration_date: The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F1 · ownership.nature: These shares are held by Lux Co-Invest Opportunities II, L.P. ("LCIO II"). Lux Co-Invest Partners II, LLC ("LCIP II") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the "Individual Lux Managers"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 18:25 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | ConversionSeries B Preferred Stock · Derivative | 530,920 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-041544 · ownership.xml · derivative · entry 10 Lux Venture Partners V, LLC · CIK 0001698118 · 10% owner Wolfe Josh · CIK 0001830001 · Director · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Lux Ventures V, L.P. · CIK 0001698008 · 10% owner Lux Co-Invest Opportunities II, L.P. · CIK 0001783916 · 10% owner Lux Total Opportunities, L.P. · CIK 0001864658 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 71,190 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F6 · price: The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F6 · derivative.exercise_date: The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F6 · derivative.expiration_date: The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F2 · ownership.nature: These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 18:25 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | ConversionSeries B Preferred Stock · Derivative | 796,380 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-041544 · ownership.xml · derivative · entry 9 Lux Venture Partners V, LLC · CIK 0001698118 · 10% owner Wolfe Josh · CIK 0001830001 · Director · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Lux Ventures V, L.P. · CIK 0001698008 · 10% owner Lux Co-Invest Opportunities II, L.P. · CIK 0001783916 · 10% owner Lux Total Opportunities, L.P. · CIK 0001864658 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 106,785 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F6 · price: The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F6 · derivative.exercise_date: The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F6 · derivative.expiration_date: The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F1 · ownership.nature: These shares are held by Lux Co-Invest Opportunities II, L.P. ("LCIO II"). Lux Co-Invest Partners II, LLC ("LCIP II") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the "Individual Lux Managers"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 18:25 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | ConversionSeries A-1 Preferred Stock · Derivative | 2,502,252 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-041544 · ownership.xml · derivative · entry 8 Lux Venture Partners V, LLC · CIK 0001698118 · 10% owner Wolfe Josh · CIK 0001830001 · Director · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Lux Ventures V, L.P. · CIK 0001698008 · 10% owner Lux Co-Invest Opportunities II, L.P. · CIK 0001783916 · 10% owner Lux Total Opportunities, L.P. · CIK 0001864658 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 335,521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F4 · price: The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F4 · derivative.exercise_date: The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F4 · derivative.expiration_date: The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F1 · ownership.nature: These shares are held by Lux Co-Invest Opportunities II, L.P. ("LCIO II"). Lux Co-Invest Partners II, LLC ("LCIP II") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the "Individual Lux Managers"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 18:25 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | ConversionSeries A-1 Preferred Stock · Derivative | 7,807,026 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-041544 · ownership.xml · derivative · entry 7 Lux Venture Partners V, LLC · CIK 0001698118 · 10% owner Wolfe Josh · CIK 0001830001 · Director · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Lux Ventures V, L.P. · CIK 0001698008 · 10% owner Lux Co-Invest Opportunities II, L.P. · CIK 0001783916 · 10% owner Lux Total Opportunities, L.P. · CIK 0001864658 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 1,046,827 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F4 · price: The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F4 · derivative.exercise_date: The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F4 · derivative.expiration_date: The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F5 · ownership.nature: These shares are held by Lux Ventures V, L.P. ("LVV"). Lux Venture Partners V, LLC ("LVPV") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 18:25 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | ConversionSeries A Preferred Stock · Derivative | 10,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-041544 · ownership.xml · derivative · entry 6 Lux Venture Partners V, LLC · CIK 0001698118 · 10% owner Wolfe Josh · CIK 0001830001 · Director · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Lux Ventures V, L.P. · CIK 0001698008 · 10% owner Lux Co-Invest Opportunities II, L.P. · CIK 0001783916 · 10% owner Lux Total Opportunities, L.P. · CIK 0001864658 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 1,340,878 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date. F3 · price: The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date. F3 · derivative.exercise_date: The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date. F3 · derivative.expiration_date: The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date. F5 · ownership.nature: These shares are held by Lux Ventures V, L.P. ("LVV"). Lux Venture Partners V, LLC ("LVPV") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 18:25 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | ConversionCommon Stock | 2,155,765 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-041544 · ownership.xml · nonDerivative · entry 5 Lux Venture Partners V, LLC · CIK 0001698118 · 10% owner Wolfe Josh · CIK 0001830001 · Director · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Lux Ventures V, L.P. · CIK 0001698008 · 10% owner Lux Co-Invest Opportunities II, L.P. · CIK 0001783916 · 10% owner Lux Total Opportunities, L.P. · CIK 0001864658 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,294,653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F7 · price: The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F8 · price: The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F9 · price: The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F10 · price: The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F2 · ownership.nature: These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 18:25 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | ConversionCommon Stock | 1,151,540 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-041544 · ownership.xml · nonDerivative · entry 4 Lux Venture Partners V, LLC · CIK 0001698118 · 10% owner Wolfe Josh · CIK 0001830001 · Director · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Lux Ventures V, L.P. · CIK 0001698008 · 10% owner Lux Co-Invest Opportunities II, L.P. · CIK 0001783916 · 10% owner Lux Total Opportunities, L.P. · CIK 0001864658 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,290,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F6 · price: The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F7 · price: The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F1 · ownership.nature: These shares are held by Lux Co-Invest Opportunities II, L.P. ("LCIO II"). Lux Co-Invest Partners II, LLC ("LCIP II") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the "Individual Lux Managers"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 18:25 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | ConversionCommon Stock | 2,387,705 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-041544 · ownership.xml · nonDerivative · entry 3 Lux Venture Partners V, LLC · CIK 0001698118 · 10% owner Wolfe Josh · CIK 0001830001 · Director · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Lux Ventures V, L.P. · CIK 0001698008 · 10% owner Lux Co-Invest Opportunities II, L.P. · CIK 0001783916 · 10% owner Lux Total Opportunities, L.P. · CIK 0001864658 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,387,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date. F4 · price: The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. F5 · ownership.nature: These shares are held by Lux Ventures V, L.P. ("LVV"). Lux Venture Partners V, LLC ("LVPV") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 18:25 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | PurchaseCommon Stock | 138,888 | $18.00 | $2,499,984.00 |
DisclosureSEC source: 0001193125-26-041544 · ownership.xml · nonDerivative · entry 2 Lux Venture Partners V, LLC · CIK 0001698118 · 10% owner Wolfe Josh · CIK 0001830001 · Director · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Lux Ventures V, L.P. · CIK 0001698008 · 10% owner Lux Co-Invest Opportunities II, L.P. · CIK 0001783916 · 10% owner Lux Total Opportunities, L.P. · CIK 0001864658 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 138,888 F2 · ownership.nature: These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 18:25 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | PurchaseCommon Stock | 138,888 | $18.00 | $2,499,984.00 |
DisclosureSEC source: 0001193125-26-041544 · ownership.xml · nonDerivative · entry 1 Lux Venture Partners V, LLC · CIK 0001698118 · 10% owner Wolfe Josh · CIK 0001830001 · Director · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Lux Ventures V, L.P. · CIK 0001698008 · 10% owner Lux Co-Invest Opportunities II, L.P. · CIK 0001783916 · 10% owner Lux Total Opportunities, L.P. · CIK 0001864658 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 138,888 F1 · ownership.nature: These shares are held by Lux Co-Invest Opportunities II, L.P. ("LCIO II"). Lux Co-Invest Partners II, LLC ("LCIP II") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the "Individual Lux Managers"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 16:12 UTC | Matterport, Inc./DE MTTR · Entity 82549 | Disposition to issuerRestricted Stock Units · Derivative | 39,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-019800 · tm258067-10_4seq1.xml · derivative · entry 2 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 39,325 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit that became fully vested automatically as a result of the consummation of the transactions (the "Closing") contemplated by the Merger Agreement (the "Accelerated Matterport RSUs") was cancelled and converted into the right to receive the Merger Consideration, and all other restricted stock units outstanding as of the effective time of the Closing were converted into a corresponding award in respect of CoStar Group Common Stock based on the Equity Award Conversion Factor (as determined in accordance with the formula in the Merger Agreement). F2 · kind: Each restricted stock unit that became fully vested automatically as a result of the consummation of the transactions (the "Closing") contemplated by the Merger Agreement (the "Accelerated Matterport RSUs") was cancelled and converted into the right to receive the Merger Consideration, and all other restricted stock units outstanding as of the effective time of the Closing were converted into a corresponding award in respect of CoStar Group Common Stock based on the Equity Award Conversion Factor (as determined in accordance with the formula in the Merger Agreement). F2 · derivative.exercise_date: Each restricted stock unit that became fully vested automatically as a result of the consummation of the transactions (the "Closing") contemplated by the Merger Agreement (the "Accelerated Matterport RSUs") was cancelled and converted into the right to receive the Merger Consideration, and all other restricted stock units outstanding as of the effective time of the Closing were converted into a corresponding award in respect of CoStar Group Common Stock based on the Equity Award Conversion Factor (as determined in accordance with the formula in the Merger Agreement). F2 · derivative.expiration_date: Each restricted stock unit that became fully vested automatically as a result of the consummation of the transactions (the "Closing") contemplated by the Merger Agreement (the "Accelerated Matterport RSUs") was cancelled and converted into the right to receive the Merger Consideration, and all other restricted stock units outstanding as of the effective time of the Closing were converted into a corresponding award in respect of CoStar Group Common Stock based on the Equity Award Conversion Factor (as determined in accordance with the formula in the Merger Agreement). Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 16:12 UTC | Matterport, Inc./DE MTTR · Entity 82549 | Disposition to issuerClass A Common Stock | 279,793 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-019800 · tm258067-10_4seq1.xml · nonDerivative · entry 1 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: In connection with the consummation of the transactions contemplated by the merger agreement (the "Merger Agreement"), dated as of April 21, 2024, by and among the Issuer, CoStar Group, Inc. ("CoStar Group") and the other parties thereto, each share of the Issuer's Class A common stock held by the Reporting Person was converted into the right to receive an amount in cash equal to $2.75 per share plus 0.03552 shares of common stock of CoStar Group (the "Merger Consideration"). F1 · price: In connection with the consummation of the transactions contemplated by the merger agreement (the "Merger Agreement"), dated as of April 21, 2024, by and among the Issuer, CoStar Group, Inc. ("CoStar Group") and the other parties thereto, each share of the Issuer's Class A common stock held by the Reporting Person was converted into the right to receive an amount in cash equal to $2.75 per share plus 0.03552 shares of common stock of CoStar Group (the "Merger Consideration"). Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 19:05 UTC | Matterport, Inc./DE MTTR · Entity 82549 | GrantRestricted Stock Unit · Derivative | 39,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005015 · primarydocument.xml · derivative · entry 3 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,325 Underlying: Class A Common Stock · 39,325 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's Class A Common Stock. F3 · shares: The reporting person has irrevocably assigned and transferred to Lux Capital Management, LLC ("LCM"), for the ratable benefit of the investment funds and other investment vehicles managed by LCM and/or its affiliates that hold securities of or other financial interests in the Company, all the reporting person's right, title and interest in and to the fees, whether payable and/or paid in cash, securities or other consideration, that the reporting person receives for his service as a director of the Company. As a result of such irrevocable assignment, the reporting person does not have any pecuniary interest in the RSUs or the shares of Class A Common Stock underlying the RSUs that are reported herein. F5 · derivative.exercise_date: The RSUs shall vest in full on the earlier to occur of (i) June 10, 2025 and (ii) the date of the Company's 2025 annual meeting of shareholders, subject to the Reporting Person's continued service with the Company through such vesting date. F5 · derivative.expiration_date: The RSUs shall vest in full on the earlier to occur of (i) June 10, 2025 and (ii) the date of the Company's 2025 annual meeting of shareholders, subject to the Reporting Person's continued service with the Company through such vesting date. F3 · derivative.underlying_shares: The reporting person has irrevocably assigned and transferred to Lux Capital Management, LLC ("LCM"), for the ratable benefit of the investment funds and other investment vehicles managed by LCM and/or its affiliates that hold securities of or other financial interests in the Company, all the reporting person's right, title and interest in and to the fees, whether payable and/or paid in cash, securities or other consideration, that the reporting person receives for his service as a director of the Company. As a result of such irrevocable assignment, the reporting person does not have any pecuniary interest in the RSUs or the shares of Class A Common Stock underlying the RSUs that are reported herein. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 19:05 UTC | Matterport, Inc./DE MTTR · Entity 82549 | Exercise / conversionRestricted Stock Unit · Derivative | 60,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005015 · primarydocument.xml · derivative · entry 2 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 60,763 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's Class A Common Stock. F3 · shares: The reporting person has irrevocably assigned and transferred to Lux Capital Management, LLC ("LCM"), for the ratable benefit of the investment funds and other investment vehicles managed by LCM and/or its affiliates that hold securities of or other financial interests in the Company, all the reporting person's right, title and interest in and to the fees, whether payable and/or paid in cash, securities or other consideration, that the reporting person receives for his service as a director of the Company. As a result of such irrevocable assignment, the reporting person does not have any pecuniary interest in the RSUs or the shares of Class A Common Stock underlying the RSUs that are reported herein. F4 · derivative.exercise_date: The RSUs vested in full on June 10, 2024, which is the date of the Company's 2024 annual meeting of shareholders. F4 · derivative.expiration_date: The RSUs vested in full on June 10, 2024, which is the date of the Company's 2024 annual meeting of shareholders. F3 · derivative.underlying_shares: The reporting person has irrevocably assigned and transferred to Lux Capital Management, LLC ("LCM"), for the ratable benefit of the investment funds and other investment vehicles managed by LCM and/or its affiliates that hold securities of or other financial interests in the Company, all the reporting person's right, title and interest in and to the fees, whether payable and/or paid in cash, securities or other consideration, that the reporting person receives for his service as a director of the Company. As a result of such irrevocable assignment, the reporting person does not have any pecuniary interest in the RSUs or the shares of Class A Common Stock underlying the RSUs that are reported herein. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 10:50 UTC | Matterport, Inc./DE MTTR · Entity 82549 | PurchaseClass A Common Stock | 50,000 | $2.50 | $124,995.00 |
DisclosureSEC source: 0001562180-23-006428 · primarydocument.xml · nonDerivative · entry 1 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,793 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.495 to $2.50. The reporting person undertakes to provide Matterport, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Amount of securities beneficially owned does not include shares of the Company's Class A common stock (the "Common Stock") owned by Lux Ventures III, L.P., Lux Ventures III Special Founders Fund, L.P., Lux Ventures Cayman III, L.P. or Lux Co-Invest Opportunities, L.P. (collectively, the "Lux Entities"). The Lux Entities separately report their ownership of the Common Stock pursuant to Section 13 of the Securities Exchange Act of 1934, as amended. Peter Hebert is a managing member of the general partners of each of the Lux Entities, and as such may be deemed to share voting and dispositive power over the shares held by the Lux Entities. Mr. Hebert disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 18:40 UTC | Matterport, Inc./DE MTTR · Entity 82549 | GrantRestricted Stock Unit · Derivative | 60,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005568 · primarydocument.xml · derivative · entry 1 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,763 Underlying: Class A Common Stock · 60,763 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's Class A Common Stock. F2 · shares: The reporting person has irrevocably assigned and transferred to Lux Capital Management, LLC ("LCM"), for the ratable benefit of the investment funds and other investment vehicles managed by LCM and/or its affiliates that hold securities of or other financial interests in the Company, all the reporting person's right, title and interest in and to the fees, whether payable and/or paid in cash, securities or other consideration, that the reporting person receives for his service as a director of the Company. As a result of such irrevocable assignment, the reporting person does not have any pecuniary interest in the RSUs or the shares of Class A Common Stock underlying the RSUs that are reported herein. F3 · derivative.exercise_date: The RSUs shall vest in full on the earlier to occur of (i) June 27, 2024 and (ii) the date of the Company's 2024 annual meeting of shareholders, subject to the Reporting Person's continued service with the Company through such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in full on the earlier to occur of (i) June 27, 2024 and (ii) the date of the Company's 2024 annual meeting of shareholders, subject to the Reporting Person's continued service with the Company through such vesting date. F2 · derivative.underlying_shares: The reporting person has irrevocably assigned and transferred to Lux Capital Management, LLC ("LCM"), for the ratable benefit of the investment funds and other investment vehicles managed by LCM and/or its affiliates that hold securities of or other financial interests in the Company, all the reporting person's right, title and interest in and to the fees, whether payable and/or paid in cash, securities or other consideration, that the reporting person receives for his service as a director of the Company. As a result of such irrevocable assignment, the reporting person does not have any pecuniary interest in the RSUs or the shares of Class A Common Stock underlying the RSUs that are reported herein. F2 · balance_after: The reporting person has irrevocably assigned and transferred to Lux Capital Management, LLC ("LCM"), for the ratable benefit of the investment funds and other investment vehicles managed by LCM and/or its affiliates that hold securities of or other financial interests in the Company, all the reporting person's right, title and interest in and to the fees, whether payable and/or paid in cash, securities or other consideration, that the reporting person receives for his service as a director of the Company. As a result of such irrevocable assignment, the reporting person does not have any pecuniary interest in the RSUs or the shares of Class A Common Stock underlying the RSUs that are reported herein. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 10:22 UTC | Matterport, Inc./DE MTTR · Entity 82549 | Exercise / conversionRestricted Stock Units · Derivative | 38,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005134 · primarydocument.xml · derivative · entry 2 Hebert Peter · CIK 0001683771 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 38,126 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vested in full on June 13, 2023, which is the date of the Company's 2023 annual meeting of shareholders. F3 · derivative.expiration_date: The RSUs vested in full on June 13, 2023, which is the date of the Company's 2023 annual meeting of shareholders. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 10:22 UTC | Matterport, Inc./DE MTTR · Entity 82549 | Exercise / conversionClass A Common Stock | 38,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005134 · primarydocument.xml · nonDerivative · entry 1 Hebert Peter · CIK 0001683771 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount of securities beneficially owned does not include shares of the Company's Class A common stock (the "Common Stock") owned by Lux Ventures III, L.P., Lux Ventures III Special Founders Fund, L.P., Lux Ventures Cayman III, L.P. or Lux Co-Invest Opportunities, L.P. (collectively, the "Lux Entities"). The Lux Entities separately report their ownership of the Common Stock pursuant to Section 13 of the Securities Exchange Act of 1934, as amended. Peter Hebert is a managing member of the general partners of each of the Lux Entities, and as such may be deemed to share voting and dispositive power over the shares held by the Lux Entities. Mr. Hebert disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 13, 2023 Filed Jun 29, 2023 18:38 UTC Amendment | Matterport, Inc./DE MTTR · Entity 82549 | Exercise / conversionRestricted Stock Units · Derivative | 38,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005567 · primarydocument.xml · derivative · entry 2 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 38,126 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's Class A Common Stock. F3 · shares: The reporting person has irrevocably assigned and transferred to Lux Capital Management, LLC ("LCM"), for the ratable benefit of the investment funds and other investment vehicles managed by LCM and/or its affiliates that hold securities of or other financial interests in the Company, all the reporting person's right, title and interest in and to the fees, whether payable and/or paid in cash, securities or other consideration, that the reporting person receives for his service as a director of the Company. As a result of such irrevocable assignment, the reporting person does not have any pecuniary interest in the RSUs or the shares of Class A Common Stock underlying the RSUs that are reported herein. F4 · derivative.exercise_date: The RSUs vested in full on June 13, 2023, which is the date of the Company's 2023 annual meeting of shareholders. F4 · derivative.expiration_date: The RSUs vested in full on June 13, 2023, which is the date of the Company's 2023 annual meeting of shareholders. F3 · derivative.underlying_shares: The reporting person has irrevocably assigned and transferred to Lux Capital Management, LLC ("LCM"), for the ratable benefit of the investment funds and other investment vehicles managed by LCM and/or its affiliates that hold securities of or other financial interests in the Company, all the reporting person's right, title and interest in and to the fees, whether payable and/or paid in cash, securities or other consideration, that the reporting person receives for his service as a director of the Company. As a result of such irrevocable assignment, the reporting person does not have any pecuniary interest in the RSUs or the shares of Class A Common Stock underlying the RSUs that are reported herein. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 17:01 UTC | Aeva Technologies, Inc. AEVA · Entity 4949 | OtherCommon Stock | 7,346,159 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-021786 · ownership.xml · nonDerivative · entry 1 Hebert Peter · CIK 0001683771 · 10% owner Wolfe Josh · CIK 0001830001 · 10% owner Lux Ventures IV, L.P. · CIK 0001633331 · 10% owner Lux Co-Invest Opportunities, L.P. · CIK 0001722022 · 10% owner Lux Venture Partners IV, LLC · CIK 0001633332 · 10% owner Lux Co-Invest Partners, LLC · CIK 0001722021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 14,692,316 F1 · kind: Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein. F1 · ownership.nature: Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein. Read SEC document |
| July 06, 2022 Filed Jul 11, 2022 18:25 UTC | Matterport, Inc./DE MTTR · Entity 82549 | GrantRestricted Stock Units · Derivative | 38,126 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-025940 · doc4.xml · derivative · entry 1 Hebert Peter · CIK 0001683771 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,126 Underlying: Class A Common Stock · 38,126 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Matterport, Inc. (the "Company") Class A common stock. F2 · derivative.exercise_date: The RSUs shall vest in full on the earlier to occur of (i) July 6, 2023 and (ii) the date of the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Company through such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in full on the earlier to occur of (i) July 6, 2023 and (ii) the date of the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Company through such vesting date. Read SEC document |
| July 06, 2022 Filed Jun 29, 2023 18:37 UTC Amendment | Matterport, Inc./DE MTTR · Entity 82549 | GrantRestricted Stock Units · Derivative | 38,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005566 · primarydocument.xml · derivative · entry 1 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,126 Underlying: Class A Common Stock · 38,126 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Matterport, Inc. (the "Company") Class A common stock. F2 · shares: The reporting person has irrevocably assigned and transferred to Lux Capital Management, LLC ("LCM"), for the ratable benefit of the investment funds and other investment vehicles managed by LCM and/or its affiliates that hold securities of or other financial interests in the Company, all the reporting person's right, title and interest in and to the fees, whether payable and/or paid in cash, securities or other consideration, that the reporting person receives for his service as a director of the Company. As a result of such irrevocable assignment, the reporting person does not have any pecuniary interest in the RSUs or the shares of Class A Common Stock underlying the RSUs that are reported herein. F3 · derivative.exercise_date: The RSUs shall vest in full on the earlier to occur of (i) July 6, 2023 and (ii) the date of the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Company through such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in full on the earlier to occur of (i) July 6, 2023 and (ii) the date of the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Company through such vesting date. F2 · derivative.underlying_shares: The reporting person has irrevocably assigned and transferred to Lux Capital Management, LLC ("LCM"), for the ratable benefit of the investment funds and other investment vehicles managed by LCM and/or its affiliates that hold securities of or other financial interests in the Company, all the reporting person's right, title and interest in and to the fees, whether payable and/or paid in cash, securities or other consideration, that the reporting person receives for his service as a director of the Company. As a result of such irrevocable assignment, the reporting person does not have any pecuniary interest in the RSUs or the shares of Class A Common Stock underlying the RSUs that are reported herein. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 20:43 UTC | Science 37 Holdings, Inc. SNCE · Entity 15235 | OtherCommon Stock | 2,914,667 | $0.00 | $0.00 |
DisclosureSEC source: 0000905718-22-000545 · science_fm4apr42022.xml · nonDerivative · entry 1 Lux Capital Management, LLC · CIK 0001592843 · 10% owner Lux Ventures IV, L.P. · CIK 0001633331 · 10% owner Lux Venture Partners IV, LLC · CIK 0001633332 · 10% owner Lux Co-Invest Opportunities, L.P. · CIK 0001722022 · 10% owner Lux Co-Invest Partners, LLC · CIK 0001722021 · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Wolfe Josh · CIK 0001830001 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Lux Ventures IV, L.P. Disclosed balance after: 8,743,999 F1 · kind: Pro rata distribution of 2,914,667 shares from Lux Ventures IV, L.P. to its partners. F2 · ownership.nature: Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares held by Lux Ventures IV, L.P. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares held by Lux Co-Invest Opportunities, L.P. Peter Hebert and Joshua Wolfe are the individual managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC and may be deemed to share voting and dispositive power over the shares held by each of Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P., Lux Capital Management, LLC, as the investment manager for each of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power over the shares held by each of Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P. F3 · ownership.nature: Each of Lux Capital Management, LLC, Lux Venture Partners IV, LLC, Lux Co-Invest Partners, LLC, Peter Hebert and Joshua Wolfe disclaim beneficial ownership over the shares reported herein except to the extent of their pecuniary interest therein, if any. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 19:41 UTC | Matterport, Inc./DE MTTR · Entity 82549 | PurchaseClass A Common Stock | 20,000 | $6.38 | $127,500.00 |
DisclosureSEC source: 0000899243-22-008182 · doc4.xml · nonDerivative · entry 1 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,793 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $6.36 to $6.40. The reporting person undertakes to provide Matterport, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Amount of securities beneficially owned does not include shares of the Company's Class A common stock (the "Common Stock") owned by Lux Ventures III, L.P., Lux Ventures III Special Founders Fund, L.P., Lux Ventures Cayman III, L.P. or Lux Co-Invest Opportunities, L.P. (collectively, the "Lux Entities"). The Lux Entities separately report their ownership of the Common Stock pursuant to Section 13 of the Securities Exchange Act of 1934, as amended. Peter Hebert is a managing member of the general partners of each of the Lux Entities, and as such may be deemed to share voting and dispositive power over the shares held by the Lux Entities. Mr. Hebert disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 07:18 UTC | Matterport, Inc./DE MTTR · Entity 82549 | OtherClass A common stock, par value $0.0001 | 209,793 | $0.00 | $0.00 |
DisclosureSEC source: 0000905718-22-000128 · matterport2_fm4jan182022.xml · nonDerivative · entry 1 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,793 F1 · kind: Pro rata distribution from certain funds and their affiliates of which the Reporting Person is a managing member, in a transaction which is exempt pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 07:16 UTC | Matterport, Inc./DE MTTR · Entity 82549 | OtherClass A Common Stock | 6,306,411 | $0.00 | $0.00 |
DisclosureSEC source: 0000905718-22-000125 · matterport_fm4jan182022.xml · nonDerivative · entry 1 Hebert Peter · CIK 0001683771 · 10% owner Wolfe Josh · CIK 0001830001 · 10% owner Lux Ventures III, L.P. · CIK 0001534238 · 10% owner Lux Ventures III Special Founders Fund, L.P. · CIK 0001534241 · 10% owner Lux Ventures Cayman III, L.P. · CIK 0001569760 · 10% owner Lux Co-Invest Opportunities, L.P. · CIK 0001722022 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 18,919,230 F1 · kind: Pro rata distribution of (i) 4,406,063 shares from Lux Ventures III, L.P. to its partners, (ii) 2,168 shares from Lux Ventures Special Founders Fund, L.P. to its partners, (iii) 209,042 shares from Lux Ventures Cayman III, L.P. to its partners, and (iv) 1,689,138 shares from Lux Co-Invest Opportunities, L.P. to its partners. Lux Venture Partners III, LLC is the general partner of each of Lux Ventures III L.P. and Lux Ventures III Special Founders Fund, L.P. and exercises voting and dispositive power over the shares held thereby. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Ventures Cayman III General Partner Limited is the general partner of Lux Ventures Cayman III, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures Cayman III, L.P. F2 · kind: (continued from footnote 1) Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited. The individual managers, as the sole managers of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures III, L.P., Lux Co-Invest Opportunities, L.P., Lux Ventures Cayman III, L.P. and Lux Ventures III Special Founders Fund, L.P. Each of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, and the individual managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein. F1 · ownership.nature: Pro rata distribution of (i) 4,406,063 shares from Lux Ventures III, L.P. to its partners, (ii) 2,168 shares from Lux Ventures Special Founders Fund, L.P. to its partners, (iii) 209,042 shares from Lux Ventures Cayman III, L.P. to its partners, and (iv) 1,689,138 shares from Lux Co-Invest Opportunities, L.P. to its partners. Lux Venture Partners III, LLC is the general partner of each of Lux Ventures III L.P. and Lux Ventures III Special Founders Fund, L.P. and exercises voting and dispositive power over the shares held thereby. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Ventures Cayman III General Partner Limited is the general partner of Lux Ventures Cayman III, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures Cayman III, L.P. F2 · ownership.nature: (continued from footnote 1) Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited. The individual managers, as the sole managers of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures III, L.P., Lux Co-Invest Opportunities, L.P., Lux Ventures Cayman III, L.P. and Lux Ventures III Special Founders Fund, L.P. Each of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, and the individual managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 20:57 UTC | RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 | OtherClass A common stock | 4,265,576 | $0.00 | $0.00 |
DisclosureSEC source: 0000905718-21-001582 · recursion_fm4dec72021.xml · nonDerivative · entry 1 Lux Ventures IV, L.P. · CIK 0001633331 · Former 10% Owner Lux Venture Partners IV, LLC · CIK 0001633332 · Former 10% Owner Lux Co-Invest Opportunities, L.P. · CIK 0001722022 · Former 10% Owner Lux Co-Invest Partners, LLC · CIK 0001722021 · Former 10% Owner Hebert Peter · CIK 0001683771 · Former 10% Owner Wolfe Josh · CIK 0001830001 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,021,519 F1 · kind: Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein. F1 · ownership.direct: Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein. Read SEC document |
| September 28, 2021 Filed Oct 5, 2021 16:31 UTC | Latch, Inc. LTCH · Entity 9606 | OtherCommon Stock | 1,358,164 | $0.00 | $0.00 |
DisclosureSEC source: 0000905718-21-001276 · latch_fm4sep282021.xml · nonDerivative · entry 2 Lux Ventures IV, L.P. · CIK 0001633331 · 10% owner Lux Venture Partners IV, LLC · CIK 0001633332 · 10% owner Lux Co-Invest Opportunities, L.P. · CIK 0001722022 · 10% owner Lux Co-Invest Partners, LLC · CIK 0001722021 · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Wolfe Josh · CIK 0001830001 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,084,493 F2 · kind: Pro rata distribution from Lux Co-Invest Opportunities, L.P. to its partners. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. The Individual Lux Managers are the individual managing members of Lux Co-Invest Partners, LLC. The Individual Lux Managers, as the sole managers of Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Co-Invest Opportunities, L.P. Each of Lux Co-Invest Partners, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest. F2 · ownership.nature: Pro rata distribution from Lux Co-Invest Opportunities, L.P. to its partners. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. The Individual Lux Managers are the individual managing members of Lux Co-Invest Partners, LLC. The Individual Lux Managers, as the sole managers of Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Co-Invest Opportunities, L.P. Each of Lux Co-Invest Partners, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest. Read SEC document |
| September 28, 2021 Filed Oct 5, 2021 16:31 UTC | Latch, Inc. LTCH · Entity 9606 | OtherCommon Stock | 2,409,489 | $0.00 | $0.00 |
DisclosureSEC source: 0000905718-21-001276 · latch_fm4sep282021.xml · nonDerivative · entry 1 Lux Ventures IV, L.P. · CIK 0001633331 · 10% owner Lux Venture Partners IV, LLC · CIK 0001633332 · 10% owner Lux Co-Invest Opportunities, L.P. · CIK 0001722022 · 10% owner Lux Co-Invest Partners, LLC · CIK 0001722021 · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Wolfe Josh · CIK 0001830001 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 7,228,469 F1 · kind: Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein. F1 · ownership.nature: Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein. Read SEC document |
| September 08, 2021 Filed Sep 10, 2021 16:56 UTC | Aeva Technologies, Inc. AEVA · Entity 4949 | OtherCommon Stock | 7,346,159 | $0.00 | $0.00 |
DisclosureSEC source: 0000905718-21-001184 · aevatech_fm4sep82021.xml · nonDerivative · entry 1 Hebert Peter · CIK 0001683771 · 10% owner Wolfe Josh · CIK 0001830001 · 10% owner Lux Ventures IV, L.P. · CIK 0001633331 · 10% owner Lux Co-Invest Opportunities, L.P. · CIK 0001722022 · 10% owner Lux Venture Partners IV, LLC · CIK 0001633332 · 10% owner Lux Co-Invest Partners, LLC · CIK 0001722021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 22,038,475 F1 · kind: Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein. F1 · ownership.nature: Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein. Read SEC document |
| October 29, 2020 Filed Nov 2, 2020 17:02 UTC | Lux Health Tech Acquisition Corp. LUXA · Entity 145615 | PurchaseWarrants · Derivative | 5,933,333 | $1.50 Strike: $11.50 | $8,899,999.50 |
DisclosureSEC source: 0000899243-20-030098 · doc4.xml · derivative · entry 1 Lux Encore Sponsor, LP · CIK 0001829620 · 10% owner Lux Encore Holdings, LLC · CIK 0001829994 · 10% owner Wolfe Josh · CIK 0001830001 · 10% owner Hebert Peter · CIK 0001683771 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,933,333 Underlying: Class A Common Stock · 5,933,333 shares Expires not disclosed F1 · derivative.exercise_date: The warrants will become exercisable commencing on the later of 12 months from the closing of the Issuer's initial public offering or 30 days after the completion of the Issuer's initial business combination, and will expire five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation. F1 · derivative.expiration_date: The warrants will become exercisable commencing on the later of 12 months from the closing of the Issuer's initial public offering or 30 days after the completion of the Issuer's initial business combination, and will expire five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation. F2 · ownership.nature: Lux Encore Sponsor, LP ("Sponsor") is the record holder of the warrants reported herein. Lux Encore Holdings, LLC ("Lux GP") is the general partner of Sponsor. Josh Wolfe and Peter Hebert are the managing members of Lux GP. As such, Lux GP and each of Messers. Wolfe and Hebert may be deemed to share beneficial ownership of the warrants held directly by Sponsor. Lux GP and Messers. Wolfe and Hebert disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein, if any. Read SEC document |
| May 19, 2020 Filed May 20, 2020 18:07 UTC | EVERSPIN TECHNOLOGIES INC. MRAM · Entity 5701 | GrantCommon Stock | 20,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030999 · doc4.xml · nonDerivative · entry 1 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,131 Read SEC document |
| May 21, 2019 Filed May 22, 2019 16:56 UTC | EVERSPIN TECHNOLOGIES INC. MRAM · Entity 5701 | GrantNonqualified Stock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001209191-19-032101 · doc4.xml · derivative · entry 3 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-05-20 F2 · derivative.exercise_date: 1/12th of the shares subject to the option vest in successive equal monthly installments measured from May 21, 2019. Read SEC document |
| May 21, 2019 Filed May 22, 2019 16:56 UTC | EVERSPIN TECHNOLOGIES INC. MRAM · Entity 5701 | GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032101 · doc4.xml · nonDerivative · entry 1 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Read SEC document |
| May 21, 2018 Filed May 22, 2018 18:00 UTC | EVERSPIN TECHNOLOGIES INC. MRAM · Entity 5701 | GrantNonqualified Stock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-18-032400 · doc4.xml · derivative · entry 3 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-05-20 F2 · derivative.exercise_date: 1/12th of the shares subject to the option vest in successive equal monthly installments measured from May 21, 2018. Read SEC document |
| May 21, 2018 Filed May 22, 2018 18:00 UTC | EVERSPIN TECHNOLOGIES INC. MRAM · Entity 5701 | GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-032400 · doc4.xml · nonDerivative · entry 1 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Read SEC document |
| October 13, 2016 Filed Oct 17, 2016 16:26 UTC | EVERSPIN TECHNOLOGIES INC. MRAM · Entity 5701 | Conversion5% Convertible Subordinated Promissory Note · Derivative | Not disclosed | $0.00 Strike: $6.40 | $570,037.52 |
DisclosureSEC source: 0001209191-16-146045 · doc4.xml · derivative · entry 9 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 89,946 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · reported_value: The notes were issued in the original principal amount of $547,094.52 to LVII and $22,943.00 to Sidecar. The outstanding principal and accrued interest on such notes automatically converted into shares of common stock of the Issuer immediately prior to the closing of the Issuer's initial public offering at a conversion rate equal to 80% of the initial public offering price. The notes bore interest at a rate of 5% per annum. The notes had accrued interest of $5,396.00 for LVII and $226.29 for Sidecar through October 12, 2016. F12 · derivative.exercise_date: The notes were issued in the original principal amount of $547,094.52 to LVII and $22,943.00 to Sidecar. The outstanding principal and accrued interest on such notes automatically converted into shares of common stock of the Issuer immediately prior to the closing of the Issuer's initial public offering at a conversion rate equal to 80% of the initial public offering price. The notes bore interest at a rate of 5% per annum. The notes had accrued interest of $5,396.00 for LVII and $226.29 for Sidecar through October 12, 2016. F12 · derivative.expiration_date: The notes were issued in the original principal amount of $547,094.52 to LVII and $22,943.00 to Sidecar. The outstanding principal and accrued interest on such notes automatically converted into shares of common stock of the Issuer immediately prior to the closing of the Issuer's initial public offering at a conversion rate equal to 80% of the initial public offering price. The notes bore interest at a rate of 5% per annum. The notes had accrued interest of $5,396.00 for LVII and $226.29 for Sidecar through October 12, 2016. F12 · ownership.nature: The notes were issued in the original principal amount of $547,094.52 to LVII and $22,943.00 to Sidecar. The outstanding principal and accrued interest on such notes automatically converted into shares of common stock of the Issuer immediately prior to the closing of the Issuer's initial public offering at a conversion rate equal to 80% of the initial public offering price. The notes bore interest at a rate of 5% per annum. The notes had accrued interest of $5,396.00 for LVII and $226.29 for Sidecar through October 12, 2016. Read SEC document |
| October 13, 2016 Filed Oct 17, 2016 16:26 UTC | EVERSPIN TECHNOLOGIES INC. MRAM · Entity 5701 | Conversion5% Convertible Subordinated Promissory Note · Derivative | Not disclosed | $0.00 Strike: $6.40 | $814,399.00 |
DisclosureSEC source: 0001209191-16-146045 · doc4.xml · derivative · entry 8 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 131,719 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · reported_value: The notes were issued in the original principal amount of $781,563.56 to LVII and $32,775.44 to Sidecar. The outstanding principal and accrued interest on such notes automatically converted into shares of common stock of the Issuer immediately prior to the closing of the Issuer's initial public offering at a conversion rate equal to 80% of the initial public offering price. The notes bore interest at a rate of 5% per annum. The notes had accrued interest of $27,515.32 for LVII and $1,153.88 for Sidecar through October 12, 2016. F11 · derivative.exercise_date: The notes were issued in the original principal amount of $781,563.56 to LVII and $32,775.44 to Sidecar. The outstanding principal and accrued interest on such notes automatically converted into shares of common stock of the Issuer immediately prior to the closing of the Issuer's initial public offering at a conversion rate equal to 80% of the initial public offering price. The notes bore interest at a rate of 5% per annum. The notes had accrued interest of $27,515.32 for LVII and $1,153.88 for Sidecar through October 12, 2016. F11 · derivative.expiration_date: The notes were issued in the original principal amount of $781,563.56 to LVII and $32,775.44 to Sidecar. The outstanding principal and accrued interest on such notes automatically converted into shares of common stock of the Issuer immediately prior to the closing of the Issuer's initial public offering at a conversion rate equal to 80% of the initial public offering price. The notes bore interest at a rate of 5% per annum. The notes had accrued interest of $27,515.32 for LVII and $1,153.88 for Sidecar through October 12, 2016. F11 · ownership.nature: The notes were issued in the original principal amount of $781,563.56 to LVII and $32,775.44 to Sidecar. The outstanding principal and accrued interest on such notes automatically converted into shares of common stock of the Issuer immediately prior to the closing of the Issuer's initial public offering at a conversion rate equal to 80% of the initial public offering price. The notes bore interest at a rate of 5% per annum. The notes had accrued interest of $27,515.32 for LVII and $1,153.88 for Sidecar through October 12, 2016. Read SEC document |
| October 13, 2016 Filed Oct 17, 2016 16:26 UTC | EVERSPIN TECHNOLOGIES INC. MRAM · Entity 5701 | ConversionSeries B Preferred Stock · Derivative | 118,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-146045 · doc4.xml · derivative · entry 7 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 118,606 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The reported securities converted into shares of the Issuer's common stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F1 · derivative.exercise_date: The reported securities converted into shares of the Issuer's common stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F1 · derivative.expiration_date: The reported securities converted into shares of the Issuer's common stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F10 · ownership.nature: The shares were held as follows: 113,833 by LV II and 4,773 by Sidecar. Read SEC document |
| October 13, 2016 Filed Oct 17, 2016 16:26 UTC | EVERSPIN TECHNOLOGIES INC. MRAM · Entity 5701 | ConversionSeries A Preferred Stock · Derivative | 219,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-146045 · doc4.xml · derivative · entry 6 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 219,916 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The reported securities converted into shares of the Issuer's common stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F1 · derivative.exercise_date: The reported securities converted into shares of the Issuer's common stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F1 · derivative.expiration_date: The reported securities converted into shares of the Issuer's common stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F9 · ownership.nature: The shares were held as follows: 211,065 by LV II and 8,851 by Sidecar. Read SEC document |
| October 13, 2016 Filed Oct 17, 2016 16:26 UTC | EVERSPIN TECHNOLOGIES INC. MRAM · Entity 5701 | PurchaseCommon Stock | 137,420 | $8.00 | $1,099,360.00 |
DisclosureSEC source: 0001209191-16-146045 · doc4.xml · nonDerivative · entry 5 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,015,550 F3 · ownership.nature: Lux Venture Partners II, L.P. ("LVPII") is the general partner of LVII and Sidecar. Lux Venture Associates II, LLC ("LVAII") is the general partner of LVPII and Lux Capital Management, LLC ("LCM LLC") is the sole member of LVAII. Mr. Hebert is an individual manager of LCM LLC. F4 · ownership.nature: LCM LLC, as sole member of LVAII, may be deemed to share voting and investment powers for the shares held by LVII and Sidecar. Mr. Hebert disclaims beneficial ownership over the shares reported herein, and this report shall not be deemed an admission of beneficial ownership for the purposes of Section 16 or for any other purpose, except to the extent of his proportionate pecuniary interest therein. F8 · ownership.nature: The shares are held as follows: 974,678 by LV II and 40,872 by Sidecar. Read SEC document |
| October 13, 2016 Filed Oct 17, 2016 16:26 UTC | EVERSPIN TECHNOLOGIES INC. MRAM · Entity 5701 | ConversionCommon Stock | 89,946 | $6.40 | $575,654.40 |
DisclosureSEC source: 0001209191-16-146045 · doc4.xml · nonDerivative · entry 4 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 878,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.nature: Lux Venture Partners II, L.P. ("LVPII") is the general partner of LVII and Sidecar. Lux Venture Associates II, LLC ("LVAII") is the general partner of LVPII and Lux Capital Management, LLC ("LCM LLC") is the sole member of LVAII. Mr. Hebert is an individual manager of LCM LLC. F4 · ownership.nature: LCM LLC, as sole member of LVAII, may be deemed to share voting and investment powers for the shares held by LVII and Sidecar. Mr. Hebert disclaims beneficial ownership over the shares reported herein, and this report shall not be deemed an admission of beneficial ownership for the purposes of Section 16 or for any other purpose, except to the extent of his proportionate pecuniary interest therein. F7 · ownership.nature: The shares are held as follows: 842,789 by LV II and 35,341 by Sidecar. Read SEC document |
| October 13, 2016 Filed Oct 17, 2016 16:26 UTC | EVERSPIN TECHNOLOGIES INC. MRAM · Entity 5701 | ConversionCommon Stock | 131,719 | $6.40 | $843,001.60 |
DisclosureSEC source: 0001209191-16-146045 · doc4.xml · nonDerivative · entry 3 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 788,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.nature: Lux Venture Partners II, L.P. ("LVPII") is the general partner of LVII and Sidecar. Lux Venture Associates II, LLC ("LVAII") is the general partner of LVPII and Lux Capital Management, LLC ("LCM LLC") is the sole member of LVAII. Mr. Hebert is an individual manager of LCM LLC. F4 · ownership.nature: LCM LLC, as sole member of LVAII, may be deemed to share voting and investment powers for the shares held by LVII and Sidecar. Mr. Hebert disclaims beneficial ownership over the shares reported herein, and this report shall not be deemed an admission of beneficial ownership for the purposes of Section 16 or for any other purpose, except to the extent of his proportionate pecuniary interest therein. F6 · ownership.nature: The shares are held as follows: 756,463 by LV II and 31,721 by Sidecar. Read SEC document |
| October 13, 2016 Filed Oct 17, 2016 16:26 UTC | EVERSPIN TECHNOLOGIES INC. MRAM · Entity 5701 | ConversionCommon Stock | 118,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-146045 · doc4.xml · nonDerivative · entry 2 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 656,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The reported securities converted into shares of the Issuer's common stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3 · ownership.nature: Lux Venture Partners II, L.P. ("LVPII") is the general partner of LVII and Sidecar. Lux Venture Associates II, LLC ("LVAII") is the general partner of LVPII and Lux Capital Management, LLC ("LCM LLC") is the sole member of LVAII. Mr. Hebert is an individual manager of LCM LLC. F4 · ownership.nature: LCM LLC, as sole member of LVAII, may be deemed to share voting and investment powers for the shares held by LVII and Sidecar. Mr. Hebert disclaims beneficial ownership over the shares reported herein, and this report shall not be deemed an admission of beneficial ownership for the purposes of Section 16 or for any other purpose, except to the extent of his proportionate pecuniary interest therein. F5 · ownership.nature: The shares are held as follows: 630,045 by LV II and 26,420 by Sidecar. Read SEC document |
| October 13, 2016 Filed Oct 17, 2016 16:26 UTC | EVERSPIN TECHNOLOGIES INC. MRAM · Entity 5701 | ConversionCommon Stock | 219,916 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-146045 · doc4.xml · nonDerivative · entry 1 Hebert Peter · CIK 0001683771 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 537,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The reported securities converted into shares of the Issuer's common stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2 · ownership.nature: The shares are held as follows: 516,212 by Lux Ventures II, L.P. ("LVII") and 21,647 by Lux Ventures II Sidecar, L.P. ("Sidecar"). F3 · ownership.nature: Lux Venture Partners II, L.P. ("LVPII") is the general partner of LVII and Sidecar. Lux Venture Associates II, LLC ("LVAII") is the general partner of LVPII and Lux Capital Management, LLC ("LCM LLC") is the sole member of LVAII. Mr. Hebert is an individual manager of LCM LLC. F4 · ownership.nature: LCM LLC, as sole member of LVAII, may be deemed to share voting and investment powers for the shares held by LVII and Sidecar. Mr. Hebert disclaims beneficial ownership over the shares reported herein, and this report shall not be deemed an admission of beneficial ownership for the purposes of Section 16 or for any other purpose, except to the extent of his proportionate pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.